Interleukin-3 receptor alpha (IL-3Ra) is thought to be overexpressed in patients with AML, and the expression of IL-3Ra is thought to correlate with a greater number of blasts and a poorer prognosis [118]. This evidence concerns the gene IL3RA and acute myeloid leukemia.